Establishing industrial production of components that enable expanding accessibility of pet imaging to cancer patient population. - CRP technical assistance is intended to accomplish the following for…
Ended Project Grant Awarded Last action
- Award ID
- SB1CA192499
- Recipient
-
Trace-Ability Inc. UEI S11KA2DGF4J6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $406,157
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Description
Establishing industrial production of components that enable expanding accessibility of pet imaging to cancer patient population. - CRP technical assistance is intended to accomplish the following for tracer-QC product under development. IT will establish industrial production methods (specifically high-precision injection molding) necessary to ensure consistent and controlled scale-up manufacturing of tracer-QC analysis plates that are currently manufactured by non-salable, variable and costly machining process. CRP problem. Trace-ability is focusing a lot of current effort on scaling up tracer-QC kit production to the levels that can supply the entire pet industry with high-quality kits. However, there is one aspect where the current manufacturing technology is not scalable and carries quality risks. IT needs to be replaced by a completely new technology in order to support the pet industry. Specifically, IT is the manufacturing of the core tracer-QC analysis plate in which all QC assessments take place. Current plates are made by cutting standard 384-well plates. Such process is not scalable. IT has inherent plate-to-plate variability and a high risk of debris contaminating the wells required for precise optical analysis. CRP solution. Trace-ability has developed a proposal together with agilent technologies, INC. To manufacture analysis plates by injection molding. This project is designed to establish scalable production of analysis plates and RE- validate all existing tracer-QC assays in these plates. Specific aim 1: scalable injection molding process for manufacturing high-quality analysis plates. The "high-quality" acceptance criteria are (a) well absorbance
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $93,843 | |
| Amendment | $156,157 | |
| Original award | $156,157 |
Quick answers
Who received award SB1CA192499?
SB1CA192499 was awarded to Trace-Ability Inc. by National Cancer Institute (National Institutes of Health) on May 1, 2023.
How much is award SB1CA192499 worth?
$406,157 has been obligated on SB1CA192499.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award